A targeted antibody‑drug conjugate shrinks tumors and slows progression in recurrent uterine cancer by ferrying potent ...

A Trop-2-directed antibody-drug conjugate, sacituzumab govitecan (SG), demonstrates encouraging efficacy in a pretreated ...

Embryo transfers were less successful, despite histologic complete remission ...

The TroFuse-005 trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum ...

Quivers was first diagnosed with endometrial cancer in 2012, which returned in 2017.

The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...

Diagnosed with endometrial cancer, Rebecca Oh thought the hardest part would be treatment. But surviving the disease was only part of it – navigating life as a young cancer patient was harder, a gap ...

"These increasing trends of uterine cancers in women aged 20-49 years indicate the need for increased awareness about modifiable risk factors (e.g., obesity) as well as the need to be aware of ...

Most uterine cancers have excellent five-year survival rates – up to 95% for localized cancer. Serous uterine cancer is an exception, with five-year survival rates of 35% to 50% for stage 1 or 2 ...

Symptoms of uterine cancer may include unusual vaginal bleeding, pain in the pelvic region, or unexplained weight loss. A person should contact a doctor if they experience these symptoms. Although ...